Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05691192

Cognitive Reserve-building Activities in Multiple Sclerosis

Conditions: Multiple Sclerosis

Sex: All
Ages: 18 Years – 65 Years
Phase: PHASE2
Enrollment: 60
Sponsor: Rigshospitalet, Denmark

Location: Denmark

Summary

The study is a crossover randomized controlled trial investigating the effect of increasing engagement in cognitive leisure activities on objective and subjective measures of cognition in individuals with multiple sclerosis.

Eligibility Criteria

Inclusion Criteria:RRMS, SPMS or PPMSAge 18-65EDSS score ≤ 6.5SDMT (or PASAT) score below -1 SDNo depression based on the MDIAble to use computer or smartphone and has internet accessIf in treatment with one or more of the following medications, the dosage must be stable:CannabinoidsAnticholinergic medicationsSedatives e.g., benzodiazepinesOpioidsAntispasmodicsBeta-blockersAntidepressant medicationFampridineExclusion Criteria:Planned start-up or discontinuation of one or more of the above-mentioned medicationsStructural brain changes following previous head trauma or neurological conditions other than which lead to structural changes or affect cognitive abilitiesEpilepsySignificant psychiatric co-morbiditySignificant somatic co-morbidity including, but not limited to, severe cardiovascular disease as well as liver, kidney, and endocrine diseasesRelapse 3 months prior to inclusion

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05691192). StuddyBuddy aggregates publicly available trial information.